Business Wire07.14.21
DataRobot, the leader in enterprise AI, has announced DataRobot’s AI for Health Incubator, a new initiative that invites entrepreneurs, companies, institutions, colleges and universities, and non-profits to develop and deploy novel solutions for the health and healthcare market. DataRobot’s AI for Health Incubator, which was unveiled during DataRobot’s AI Experience Worldwide, will provide pro-bono access to the DataRobot platform and hands-on support from its customer success teams.
DataRobot works with some of the most sophisticated healthcare organizations in the world to transform billions of data points into insights and predictions that help improve quality of care and ultimately save lives. Customers use DataRobot for a myriad of use cases, including reducing patient readmissions, ICU resource and staffing utilization, improving medication adherence, predicting opioid abuse, and forecasting disease propensity.
DataRobot has also been supporting a number of critical efforts to beat COVID-19. In early 2020, DataRobot used its platform, experience, and partners to produce rapid, transformative solutions, including a COVID-19 long-term forecasting and simulation decision intelligence platform. This platform was used by the federal government to identify the impacted communities from a national to county level, provide models that identify and enable individuals unaware of virus spread to take action, and provide key guidance for vaccine trial and testing strategies.
“When it comes to thinking about healthcare, it’s safe to say 2020 changed the name of the game,” said Sally Embrey, vice president of Public Health and Health Technologies, DataRobot. “We’re at a critical moment in time for the industry and believe we have an opportunity to truly democratize healthcare in a transparent and trustworthy way. We’re pleased to build on the important work we’ve done in the healthcare sector and collaborate with the next generation of innovators in the industry to solve big problems, particularly ones that have a direct impact on patient populations and long-term health outcomes.”
Dr. Zain Khalpey, chief of Cardiothoracic Surgery and chief medical Artificial Intelligence Officer, director of Heart & Vascular Institute at Northwest Medical Center, is DataRobot’s first AI for Health Incubator partner. He’s working alongside DataRobot on research designed to not only use AI to help patients in the OR and in the ICU, but to also predict medical interventions and deploy preventative strategies in healthcare.
“The future of healthcare is rooted in the ability to bring human and machine intelligence together to make better, faster, and more efficient decisions we can trust,” said Khalpey. “DataRobot is accelerating critical research in this industry to help physicians and medical professionals better leverage AI. The impact on human lives if we get this right will be immeasurable. I’m excited to work with DataRobot because together, we’re able to make augmented medical decision-making—a new formula which will be the future of healthcare driven by AI.”
DataRobot is the leader in enterprise AI, delivering trusted AI technology and enablement services to global enterprises competing in today’s Intelligence Revolution. DataRobot’s enterprise AI platform democratizes data science with end-to-end automation for building, deploying, and managing machine learning models. This platform maximizes business value by delivering AI at scale and continuously optimizing performance over time. The company’s proven combination of cutting-edge software and world-class AI implementation, training, and support services, empowers any organization—regardless of size, industry, or resources—to drive better business outcomes with AI. DataRobot has offices across the globe and funding from some of the world’s best investing firms including Alliance Bernstein, Altimeter, B Capital Group, Cisco, Citi Ventures, ClearBridge, DFJ Growth, Geodesic Capital, Glynn Capital, Intel Capital, Meritech, NEA, Salesforce Ventures, Sands Capital, Sapphire Ventures, Silver Lake Waterman, Snowflake Ventures, Tiger Global, T. Rowe Price, and World Innovation Lab.
DataRobot works with some of the most sophisticated healthcare organizations in the world to transform billions of data points into insights and predictions that help improve quality of care and ultimately save lives. Customers use DataRobot for a myriad of use cases, including reducing patient readmissions, ICU resource and staffing utilization, improving medication adherence, predicting opioid abuse, and forecasting disease propensity.
DataRobot has also been supporting a number of critical efforts to beat COVID-19. In early 2020, DataRobot used its platform, experience, and partners to produce rapid, transformative solutions, including a COVID-19 long-term forecasting and simulation decision intelligence platform. This platform was used by the federal government to identify the impacted communities from a national to county level, provide models that identify and enable individuals unaware of virus spread to take action, and provide key guidance for vaccine trial and testing strategies.
“When it comes to thinking about healthcare, it’s safe to say 2020 changed the name of the game,” said Sally Embrey, vice president of Public Health and Health Technologies, DataRobot. “We’re at a critical moment in time for the industry and believe we have an opportunity to truly democratize healthcare in a transparent and trustworthy way. We’re pleased to build on the important work we’ve done in the healthcare sector and collaborate with the next generation of innovators in the industry to solve big problems, particularly ones that have a direct impact on patient populations and long-term health outcomes.”
Dr. Zain Khalpey, chief of Cardiothoracic Surgery and chief medical Artificial Intelligence Officer, director of Heart & Vascular Institute at Northwest Medical Center, is DataRobot’s first AI for Health Incubator partner. He’s working alongside DataRobot on research designed to not only use AI to help patients in the OR and in the ICU, but to also predict medical interventions and deploy preventative strategies in healthcare.
“The future of healthcare is rooted in the ability to bring human and machine intelligence together to make better, faster, and more efficient decisions we can trust,” said Khalpey. “DataRobot is accelerating critical research in this industry to help physicians and medical professionals better leverage AI. The impact on human lives if we get this right will be immeasurable. I’m excited to work with DataRobot because together, we’re able to make augmented medical decision-making—a new formula which will be the future of healthcare driven by AI.”
DataRobot is the leader in enterprise AI, delivering trusted AI technology and enablement services to global enterprises competing in today’s Intelligence Revolution. DataRobot’s enterprise AI platform democratizes data science with end-to-end automation for building, deploying, and managing machine learning models. This platform maximizes business value by delivering AI at scale and continuously optimizing performance over time. The company’s proven combination of cutting-edge software and world-class AI implementation, training, and support services, empowers any organization—regardless of size, industry, or resources—to drive better business outcomes with AI. DataRobot has offices across the globe and funding from some of the world’s best investing firms including Alliance Bernstein, Altimeter, B Capital Group, Cisco, Citi Ventures, ClearBridge, DFJ Growth, Geodesic Capital, Glynn Capital, Intel Capital, Meritech, NEA, Salesforce Ventures, Sands Capital, Sapphire Ventures, Silver Lake Waterman, Snowflake Ventures, Tiger Global, T. Rowe Price, and World Innovation Lab.
